UBS has upgraded Archer Daniels Midland (ADM) from Neutral to Buy, raising the price target to $60, citing potential policy benefits and a positive outlook for its nutrition segment. The company, currently trading at $50.13, is seen as undervalued with strong financial health, and is expected to benefit from increased demand for domestic soybean oil due to anticipated policy changes. Despite recent earnings exceeding expectations, ADM has adjusted its full-year EPS guidance lower, reflecting challenges in its Refined Products and Oilseeds segments.